KYMR - Kymera Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

KYMR is currently covered by 16 analysts with an average price target of $39.45. This is a potential upside of $9.28 (30.76%) from yesterday's end of day stock price of $30.17.

Kymera Therapeutics's activity chart (see below) currently has 61 price targets and 83 ratings on display. The stock rating distribution of KYMR is 37.5% HOLD and 62.5% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 70.08% with an average time for these price targets to be met of 242.8 days.

Highest price target for KYMR is $74, Lowest price target is $41, average price target is $51.07.

Most recent stock forecast was given by ANDREW FEIN from HC WAINWRIGHT on 28-Feb-2025. First documented stock forecast 15-Sep-2020.

Currently out of the existing stock ratings of KYMR, 18 are a HOLD (37.5%), 30 are a BUY (62.5%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$60

$28.65 (91.39%)

$46

3 days ago
(28-Feb-2025)

5/8 (62.5%)

$28.65 (91.39%)

45

Buy

$57

$25.65 (81.82%)

$38

3 months 1 days ago
(02-Dec-2024)

6/8 (75%)

$9.26 (19.40%)

169

Hold

$49

$17.65 (56.30%)

$45

3 months 25 days ago
(06-Nov-2024)

5/5 (100%)

$-0.48 (-0.97%)

100

Buy

$74

$42.65 (136.04%)

$80

3 months 27 days ago
(04-Nov-2024)

0/2 (0%)

$26.93 (57.21%)

Hold

$41

$9.65 (30.78%)

$36

4 months 2 days ago
(01-Nov-2024)

6/7 (85.71%)

$-5.47 (-11.77%)

218

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is KYMR (Kymera Therapeutics) average time for price targets to be met?

On average it took 242.8 days on average for the stock forecasts to be realized with a an average price target met ratio 70.08

Which analyst has the current highest performing score on KYMR (Kymera Therapeutics) with a proven track record?

EDWARD TENTHOFF

Which analyst has the most public recommendations on KYMR (Kymera Therapeutics)?

Edward Tenthoff works at PIPER SANDLER and has 5 price targets and 4 ratings on KYMR

Which analyst is the currently most bullish on KYMR (Kymera Therapeutics)?

Eliana Merle with highest potential upside - $42.65

Which analyst is the currently most reserved on KYMR (Kymera Therapeutics)?

Vikram Purohit with lowest potential downside - $2.65

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?